1. Home
  2. CLBK vs BCRX Comparison

CLBK vs BCRX Comparison

Compare CLBK & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Columbia Financial Inc.

CLBK

Columbia Financial Inc.

HOLD

Current Price

$10.81

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$8.97

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLBK
BCRX
Founded
1927
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.4B
IPO Year
2026
1995

Fundamental Metrics

Financial Performance
Metric
CLBK
BCRX
Price
$10.81
$8.97
Analyst Decision
Hold
Strong Buy
Analyst Count
1
11
Target Price
$17.00
$20.82
AVG Volume (30 Days)
6.7M
3.8M
Earning Date
04-20-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
381.40
EPS
N/A
N/A
Revenue
N/A
$25,186,000.00
Revenue This Year
$3.97
N/A
Revenue Next Year
$11.43
$12.55
P/E Ratio
$83.69
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.70
$6.00
52 Week High
$25.83
$11.22

Technical Indicators

Market Signals
Indicator
CLBK
BCRX
Relative Strength Index (RSI) 21.97 41.44
Support Level $10.70 $8.80
Resistance Level $16.27 $9.31
Average True Range (ATR) 0.56 0.34
MACD -0.81 -0.09
Stochastic Oscillator 0.83 1.46

Price Performance

Historical Comparison
CLBK
BCRX

About CLBK Columbia Financial Inc.

Columbia Financial Inc is a federally chartered savings bank that serves the financial needs of depositors and the local community as a customer service-focused institution. The company offers traditional financial services to businesses and consumers in its market areas. It attracts deposits from the general public and uses those funds to originate various loans, including multifamily and commercial real estate loans, commercial business loans, one-to-four family real estate loans, construction loans, home equity loans and advances, and other consumer loans. The company also offers title insurance through its wholly owned subsidiary and provides a broad range of insurance products, including personal and business lines of insurance, mainly to customers and New Jersey residents.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: